Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 25, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
Most bacterial gastrointestinal illnesses in Australia are thought to be caused by two pathogens, Campylobacter and Salmonella. But an emerging pathogen, Aeromonas, is much more common than previously ...
Most bacterial gastrointestinal illnesses in Australia are thought to be caused by two pathogens, Campylobacter and Salmonella. But an emerging pathogen, Aeromonas, is much more common than previously ...
Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results